ALX ONCOLOGY HOLDINGS INC. - COMMON STOCK
0.8301
14-March-25 16:45:00
15 minutes delayed
Stocks
-0.0013
-0.16%
Today's range
0.8294 - 0.8600
ISIN
N/A
Source
NASDAQ
-
ALX Oncology Appoints Alan Sandler, M.D., to Board of Directors
06 Aug 2024 16:01:00 By Nasdaq GlobeNewswire
-
31 Jul 2024 16:01:00 By Nasdaq GlobeNewswire
-
02 Jun 2024 10:00:00 By Nasdaq GlobeNewswire
-
ALX Oncology Announces Participation in the Jefferies Global Healthcare Conference
29 May 2024 09:00:01 By Nasdaq GlobeNewswire
-
ALX Oncology Reports First Quarter 2024 Financial Results and Provides Corporate Update
09 May 2024 16:00:00 By Nasdaq GlobeNewswire
-
ALX Oncology Appoints Allison Dillon as Chief Business Officer
07 May 2024 09:00:00 By Nasdaq GlobeNewswire
-
24 Apr 2024 10:00:00 By Nasdaq GlobeNewswire
-
07 Mar 2024 16:03:00 By Nasdaq GlobeNewswire
-
05 Mar 2024 16:30:00 By Nasdaq GlobeNewswire
-
ALX Oncology to Present at the 42nd Annual J.P. Morgan Healthcare Conference
03 Jan 2024 08:00:00 By Nasdaq GlobeNewswire
-
ALX Oncology Reports Third Quarter 2023 Financial Results and Provides Corporate Update
13 Nov 2023 16:05:01 By Nasdaq GlobeNewswire
-
ALX Oncology Announces November Investor Conference Participation
01 Nov 2023 16:05:00 By Nasdaq GlobeNewswire
-
10 Oct 2023 16:05:00 By Nasdaq GlobeNewswire
-
ALX Oncology Announces Pricing of Public Offering
05 Oct 2023 08:00:00 By Nasdaq GlobeNewswire
-
ALX Oncology Announces Proposed Public Offering
04 Oct 2023 16:10:18 By Nasdaq GlobeNewswire
-
03 Oct 2023 06:00:00 By Nasdaq GlobeNewswire